Burd A, Levine RL, Shoben A, et al. Initial Report of the Beat AML Umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies. ASH Annual Meeting and Exposition 2018, abstract 559.
Ibrutinib plus R-CHOP bij jongere patiënt met ‘non-germinal center B-cell’ DLBCL?
jun 2019 | Lymfoom